Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 239
-8
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Making Inexpensive Insulin Using Microalgae

This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

Can personalized medicine subtype bladder cancer?

Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Backer Badge Funded